1.4.2. Rationale and Union added value

Powered by the expansion of the knowledge of living systems, biotechnology is set to deliver a stream of new applications and to strengthen the Union's industrial base and its innovation capacity. Examples of the rising importance of biotechnology are in industrial applications including biopharmaceuticals, food and feed production and biochemicals, of which the market share of the latter is estimated to increase by up to 12 % to 20 % of chemical production by 2015. A number of the so-called twelve principles of Green Chemistry are also addressed by biotechnology, due to the selectivity and efficiency of biosystems. The possible economic burdens for Union enterprises can be reduced by harnessing the potential of biotechnology processes and bio-based products to reduce CO_(2) emissions, estimated to range from between 1 to 2,5 billion tonnes CO_(2) equivalent per year by 2030. In Europe's biopharmaceutical sector, already some 20 % of the current medicines are derived from biotechnology, with up to 50 % of new medicines. Biotechnology will play a major role in the transition towards a bio-based economy by developing new industrial processes. Biotechnology also opens new avenues for the development of a sustainable agriculture, aquaculture and forestry and for exploiting the huge potential of marine resources for producing innovative industrial, health, energy, chemical and environmental applications. The emerging sector of marine (blue) biotechnology has been predicted to grow by 10 % a year. Other key sources of innovation are at the interface between biotechnology and other enabling and converging technologies, in particular nanotechnologies and ICT, with applications such as sensing and diagnosing.

← anx_I__cpt_21__cpt_1__cpt_8__cpt_1__text_2 · All articles · anx_I__cpt_21__cpt_1__cpt_8__cpt_2__text_1 →

Source: EUR-Lex (Cellar) · retrieved 2026-11-03 · Text as adopted (Official Journal); later amendments are not incorporated in this text.